Pharmafile Logo

B2B sales

- PMLiVE

Novartis claims first CAR-T approval, setting $475k price tag

Kymriah receives FDA nod to treat ALL patients

Eli Lilly HQ

Lilly planning early re-file for JAK inhibitor baricitinib

The arthritis treatment could reach US market a year earlier than expected

- PMLiVE

Three ‘finalist’ nominations for Porterhouse Medical in the 2017 Women in Business Awards

The 2017 Women in Business Awards shortlist (http://womeninbusiness.biz/wib-awards-2017/) includes an impressive three ‘finalist’ nominations for Porterhouse Medical across three award categories. Senior Medical Writers Lisa Gallacher and Gillian Hancey have...

Porterhouse Medical Group

- PMLiVE

Sanofi looks to mobile data to power behavioural analysis

Teams up with Evidation Health for a new digital health partnership

- PMLiVE

McCann Echo strengthens leadership team

Promotes Jesse Johanson as its president

Life at the end of the Brexit tunnel

A new proposal to maintain the UK as a benchmark of excellence in Life Sciences

Life Healthcare Communications

- PMLiVE

Merck & Co’s anacetrapib data fails to generate much excitement

Treatment proves unable to reduce a composite outcome of major atherosclerotic events

Biogen Idec building

Biogen says trial extension data keep Alzheimer’s drug on track

Releases updated results from the PRIME trial of anti-amyloid drug aducanumab

- PMLiVE

EUSA receives European green light for kidney cancer treatment Fotivda

European Commission approves the drug to treat RCC

- PMLiVE

Boehringer Ingelheim launches new digital innovation team

BI X will aim to accelerate research and development

- PMLiVE

mXm launches mXm Health Consulting

Strategic consulting arm to operate alongside mXm Medical Communications

- PMLiVE

Almirall appoints Peter Guenter as its CEO

He joins from Sanofi where he was executive vice president

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links